Position in PLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$120,403
-$534,485 QoQ
Shares Held
51,676
-82.9% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 101 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. PLX ranks #342 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in PLX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,403 | 51,676 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $654,888 | 301,793 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $237,576 | 131,987 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $157,700 | 71,037 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $683,823 | 462,043 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $213,907 | 83,558 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $320,005 | 170,216 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $43,919 | 43,058 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $101,956 | 87,144 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $218,067 | 173,071 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $444,109 | 249,500 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $330,065 | 198,835 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $274,594 | 137,297 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $172,569 | 82,176 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,256 | 8,217 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,545 | 8,217 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,956 | 8,217 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $25,352 | 23,917 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,073,158 | 1,292,963 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,039,149 | 2,285,075 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,556,073 | 1,861,819 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $223 | 50 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $181 | 50 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $193 | 50 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $23 | 10 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||